Background. Hemangiomas are classified as hamartomas, representing an anomalous proliferation of endothelium-lined
vessels. Zygomatic and nasal bone hemangiomas are quite rare. Localized in the nasal cavity and paranasal sinuses,
hemangioma arises from soft tissues, but in the future it can cause bone destruction of the surrounding tissues and
manifests itself, as a rule, in the form of recurrent nosebleeds, hemoptysis and difficulty in nasal breathing. Non-radical
removal of a tumor-like formation leads to recurrence, therefore, the main method of treating hemangiomas, especially
deep ones, is surgical excision with preoperative embolization to reduce intraoperative bleeding.
Case description. Patient S., 65 years old, was admitted with complaints of difficulty in nasal breathing, more
on the right, pulling pain in the formation of the back and slope of the nose, headache, deformity of the external nose.
A biopsy of the formation of the nasal cavity was performed, according to which: arteriovenous hemangioma of the anterior
cells of the ethmoid labyrinth on the right, the right half of the nose, extending into the soft tissues of the external nose,
the adjacent basal parts of both frontal sinuses. In order to prevent bleeding, before removing the vascular formation,
CT angiography was performed followed by selective embolization of the right maxillary artery that feeds it. The vascular
anomaly was surgically removed and a bone defect plasty was performed.
Outcomes. A 65-year-old patient successfully underwent surgical treatment of hemangioma of the nasal cavity and
paranasal sinuses, with preliminary embolization of adductor vessels by radical excision of arteriovenous malformation,
followed by bone defect plasty with a titanium plate. There were no complications in the postoperative period.
Key words: Hemangioma, nose, paranasal sinuses, vascular anomalies, arteriovenous malformation
Conflicts of interest. The authors have no conflicts of interest to declare.
Funding. The research was funded from the authors’ own funds.